Watch Ticker

Amphastar Pharmaceuticals, Inc.

Go to Amphastar Pharmaceuticals, Inc. Website

$21.40

0.00 (0.00%)

Live

Previous Close

$21.4

Day Range

$0 - $0

Previous Day Range

$20.878045 - $21.43

Market Cap

$999.8 million USD

Day Vol.

Previous Day Vol.

463650

Currency

USD

Primary Exchange

Nasdaq

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight

The dilated cardiomyopathy market is witnessing substantial growth, driven by advancements in cardiovascular therapies and the increasing incidence of the condition. Key factors contributing to the market's upward momentum include greater public awareness, government initiatives, and continuous progress in product innovation.

Related tickers: AMRX, AMPH.

Read Full Article

Vandana Singh - JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

The specialty pharma sector is showing signs of stability, with modest growth and valuations recovering to historical averages. JP Morgan is most interested in Teva and Organon, maintaining a neutral rating on Teva due to its branded pipeline and caution about its U.S. generic business, while giving an underweight rating to Organon due to its recent stock price surge.

Related tickers: TEVA, OGN, VTRS, PRGO, AMPH, AMRX.

Read Full Article

Trending Tickers

Please sign in to view